Cogent Biosciences, Inc. COGT Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $269.78M+16.0% | $232.66M+33.9% | $173.76M+42.9% | $121.63M+118% | ||
| $63.58M+46.9% | $43.28M+25.9% | $34.38M+31.1% | $26.21M+33.5% | ||
| $333.36M+20.8% | $275.94M+32.6% | $208.13M+40.8% | $147.84M+95.7% | ||
| -$333.36M-20.8% | -$275.94M-32.6% | -$208.13M-40.8% | -$147.84M-95.7% | ||
| $3.06M— | —— | —— | —— | ||
| —— | $20.08M+27.7% | $15.72M+107% | $7.6M+132% | ||
| -$328.94M-28.6% | -$255.86M-33.0% | -$192.41M-37.2% | -$140.24M-94.0% | ||
| -$2.16-11.3% | -$1.94-0.5% | -$1.93-2.1% | -$1.89-1.1% | ||
| -$330.79M-20.9% | -$273.5M-32.9% | -$205.86M-40.0% | -$147M-94.9% | ||
| -$333.36M-20.8% | -$275.94M-32.6% | -$208.13M-40.8% | -$147.84M-95.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Cogent Biosciences, Inc.'s income statement data come from?
- Every line is extracted from Cogent Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.